SCHEMBL7133993

SCHEMBL7133993

Cc1c(Br)cc(Br)c2c1C(=Cc1ccc(O)cc1)C(=O)N2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP1 P53582 1/20 0.50
RET P07949 2/20 0.44
FLT3 P36888 1/20 0.44
PLK4 O00444 1/20 0.44
PDGFRB P09619 1/20 0.44
PLK1 P53350 1/20 0.44
PSEN1 P49768 1/20 0.43
PSEN2 P49810 1/20 0.43
APH1B Q8WW43 1/20 0.43
NCSTN Q92542 1/20 0.43
APH1A Q96BI3 1/20 0.43
PSENEN Q9NZ42 1/20 0.43
LRRK2 Q5S007 1/20 0.43
GSK3B P49841 5/20 0.41
APP P05067 1/20 0.41
MAPT P10636 1/20 0.41
SNCA P37840 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138182 0.89 KMT2A (0.42) RETPLK4MAPTALDH1A1MEN1
SCHEMBL7138862 0.89 MAPT (0.47) METAP1RETMAPTALDH1A1MEN1
SCHEMBL7130885 0.88 SIRT1 (0.41) METAP1RETPLK4PLK1PSEN1
SCHEMBL7138262 0.87 LRRK2 (0.51) PLK4LRRK2MAPTALDH1A1MEN1
SCHEMBL8193593 0.87 PLK4 (0.51) PLK4LRRK2MAPTALDH1A1MEN1
SCHEMBL7135160 0.87 METAP1 (0.50) METAP1RETPDGFRBMAPTALDH1A1
SCHEMBL7136076 0.87 LRRK2 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7136101 0.86 RET (0.44) RETLRRK2MEN1KMT2AHPGD
SCHEMBL7132053 0.86 METAP1 (0.53) METAP1RETMAPTALDH1A1MEN1
SCHEMBL7139926 0.86 LRRK2 (0.42) PLK4LRRK2MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6506763-B2 Useful in prevention and treatment of protein kinase related disorders such as cancer SUGEN, INC. 2003-01-14 US disclosed
EP-0984930-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY Sugen, Inc. (US) 2000-03-15 EP disclosed
WO-1998050356-A1 2-INDOLINONE DERIVATIVES AS MODULATORS OF PROTEIN KINASE ACTIVITY SUGEN, INC. (US) 1998-11-12 WO disclosed